Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A curated listing of global health funding opportunities.

The Global Health Research Professorship award is NIHR’s flagship career development award. It aims to fund research leaders to promote effective translation of research and to strengthen research leadership at the highest academic levels.

The Global Health Research Professorship programme supports outstanding academics to work at professorial level. The programme funds researchers undertaking research that aims to specifically and primarily benefit people in LMICs eligible for Official Development Assistance (ODA).

The award provides an extensive support package alongside the professorship, to include support posts, research costs and a leadership and development programme.

The scheme is open to all health, public health and social care research and methodology professions. Applicants must be nominated by their host institution, so see details of obligatory internal coordinated bid.

 

The GHIT Fund announces the Request for Proposals (RFP) for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world. Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases. The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:

- Lead optimization

- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation)

- Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

- Parallel or concurrent development of multiple interventions (e.g., development of new drugs alongside improved diagnostic tools for disease control, advancing multiple promising drug candidates concurrently)

- Activities to support licensure and WHO prequalification 

Interested applicants can find detailed information on the RFP and the Intent to Apply form on their website. Please note interested applicants must complete the Intent to Apply (ITA) form and submit this to the GHIT Fund by 28 November 2024.  Full applications are then due 16 January 2025.

The GHIT Fund announces the Request for Proposals (RFP) for the Target Research Platform (TRP). The TRP is currently focused on technologies and approaches that address unmet or priority needs within malaria, tuberculosis, Neglected Tropical Diseases and disease with pandemic potential listed in the GHIT Intent to Apply form.

Proposed projects should primarily originate from or materially involve Japanese science and technology and partnerships will need to be between eligible Japanese and non-Japanese organizations.

Interested applicants can find detailed information on the RFP and the Intent to Apply form. Please note interested applicants must complete the Intent to Apply (ITA) form and submit this to the GHIT Fund by 28 November 2024.  Full applications are then due 16 January 2025.

 

 

 

This award will fund projects to advance understanding of how heat impacts anxiety, depression, and psychosis in the most impacted groups globally through biological, psychological, and/or social mechanisms. Teams must bring together mental health and climate expertise as well as additional expertise as relevant. Consistent with the Wellcome approach to mental health research, it is expected that research teams to include relevant lived experience of mental health problems, unless there is a strong justification for not doing so. Researchers can be based in institutions anywhere in the world (apart from mainland China and countries that are the target of international sanctions). Scope check deadline 18 December 2024.

Find out more and apply

 

ABOUT

This award will support studies that explore the mechanisms and triggers for fungal adaptation, particularly in environments that are associated with disease and/or impacted by climate change. Awardees will generate important breakthroughs in the field, strengthen research networks and empower future leaders in this field.  

Amount: Up to £3 million for up to 5 years.   

ELIGIBILITY

 

Established and mid-career researchers

 

Learn more about the Wellcome - Biology of Fungal Adaptation Scheme

 

ABOUT

This funding call will generate a body of evidence on the health effects of climate change mitigation interventions in low- and middle-income countries (LMICs). This award will fund transdisciplinary research teams, led by an applicant at an LMIC-based institution. Research funded will investigate health effects alongside the social and economic impacts of planned or implemented greenhouse gas mitigation strategies. Research will reflect local priorities and produce evidence to drive positive climate and health outcomes. Webinar 9 December 2024. Preliminary application deadline: 18 February 2025. 

AMOUNT

£500,000-£2 million per project for 2 - 4 years  

Frequency: One-off  

ELIGIBILITY

Lead applicant career stage: Established researcher  

Co-applicants: Accepted 

Administering organisation location:  Low- or middle-income countries (apart from mainland China)  

Apply for the Wellcome Climate and Health Award

About

Funding to develop and test novel therapeutics, medical devices, diagnostics You can apply for academically-led translational projects that aim to either:

  • improve prevention, diagnosis, prognosis or treatment of significant health needs
  • develop research tools that increase the efficiency of developing interventions.

All diseases and interventions are eligible for support. You can also address global health issues. Your project can start and finish at any stage on the developmental pathway from early development, through pre-clinical refinement and testing to early-phase clinical studies and trials (up to phase 2a). You can submit follow-on proposals where you can justify the need for continued support. This is an ongoing funding opportunity. Application rounds close every March, July and November.

Amount

No limits

Apply to the MRC: Developmental Pathway Funding scheme

ABOUT

This annual grant offers early career researchers and global health professionals based anywhere in the world the opportunity to apply for funding in a topic related to tropical medicine and global health. In 2024 the RSTMH funded more than 220 Early Career Grants, their highest number yet.*** This opportunity will be available soon. The next call is expected to open in January 2025. This information is subject to change. ***

AMOUNT

Up to £5,000 over 1 year (including VAT).

ELIGIBILITY

Early career researchers and global health professionals based anywhere in the world, who have not had research funding in their own name before.

 

Apply to the Royal Society of Tropical Medicine and Hygiene: Early Career Grants Programme

ABOUT

The Medical Research Future Fund (MRFF) Australia, the National Health and Medical Research Council (NHMRC) Australia and National Institute for Health and Care Research (NIHR) UK are inviting applications for ambitious platform studies in areas of unmet medical need. The platform must be internationally collaborative, with joint leads based in Australia and the United Kingdom. 

Applications to this funding opportunity must describe a platform trial seeking to evaluate a number of specified technologies. Each technology must have sufficient clinical, human proof of concept to justify a definitive efficacy study. This call is for either Phase 2 or Phase 3 focused platforms, where there is a pipeline of technologies which justifies a platform approach. This call will not support funding for studies aiming to run platforms seamlessly from phase 2 into phase 3. See call specifications for more details. 

The funder is holding a webinar (1.5hrs) to support applicants to this funding opportunity on 19 November 2024, 08:00 UK (UTC+0)/19:00 AEDT (UTC+11). To register for the webinar, please sign up via their online form.   

Amount: Aiming to fund 1 to 3 platforms for up to 7 Years. NHMRC and MRFF will fund the Australian research component and the NIHR will fund the UK research component of successful applications.   

 

 

Learn more about the NIHR: Australia-UK platform studies in areas of unmet clinical need